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Background
To prevent HIV-1 infection induction of broadly neutra-
lising antibodies (bnAb) like 2F5 and 4E10 reacting with
the membrane proximal external region (MPER) of the
transmembrane envelope (TM) protein gp41 of HIV-1
may be essential. Since these antibodies appear late after
infection, it is thought that they require a prolonged
maturation time. Using apathogenic foamy virus (FV) as
replicating gene delivery vector may allow antibody
maturation through persistent antigen presentation.
Based on studies showing an interaction of the MPER
with the fusion peptide proximal region (FPPR) in gp41,
strategies to graft these regions into backbone proteins
of FV were examined and two, comprising the FV TM
protein and the accessory Bet protein were tested here.
Methods
The feline foamy virus (FFV) TM protein and Bet hybrid
proteins comprising the MPER and FPPR of HIV-1 gp41
were produced and antibody responses were studied in
immunized and FFV infected animals by ELISA, Western
blot and microarray-based epitope mapping. Also, con-
structs for stable, high level expression of full length FFV
Env were developed.
Results
Mapping sera from animals immunized with the FFV TM
protein and infected cats revealed immunogenic epitopes
in the FV FPPR and MPER. These were exchanged
against their HIV-1 homologues in optimized FV Env.
Upon transfection, these constructs allowed production
of chimeric virus-like-particles (VLPs) currently used for
immunization studies. By immunizing with the Bet fusion
proteins containing the gp41 MPER, FPPR or MPER-
FPPR, strong responses were induced against gp41 and
the 2F5 epitope ELDKWAS, demonstrating the feasibility
of this approach. The hybrid sequences are now trans-
ferred to infectious FFV clones.
Conclusion
To induce bnAb of the type 2F5 and 4E10, the developed
vaccine systems provide two new high safety strategies for
HIV epitope delivery by either VLPs or replicating vectors.
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